C. Amrein - Concepedia

Author

C. Amrein

Hôpital Européen Georges-Pompidou

Also Known As

Amrein, Catherine, C Amrein, C. AMREIN, C. Amrein, CATHERINE Amrein, Catherine Amrein, Catherine I. Amrein

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Hôpital Européen Georges-Pompidou Hôpital Européen Université Paris Cité Assistance Publique – Hôpitaux de Paris Délégation Paris 5

About

C. Amrein is an author at Hôpital Européen Georges-Pompidou specializing in medicine, transplantation, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	671
2	Cell Biology	2	2	174
3	Allergy	1	1	17
4	Biomedical Engineering	1	1	17
5	Hepatology	1	1	103

C. Amrein

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Human Leukocyte Antigen-G Expression After Heart Transplantation Is Associated With a Reduced Incidence of Rejection Nermine Lila, C. Amrein, R. Guillemain, Circulation	2002	243
Cardiac stem cells in the real world Julia Pouly, Patrick Bruneval, Chantal Mandet, Journal of Thoracic and Cardiovascular Surgery Regenerative MedicineAdult Stem CellCardiac Progenitor CellsCardiac Stem CellsCardiac Regeneration	2008	115
Combined lung and liver transplantation in patients with cystic fibrosis: A 4 1/2-year experience Jean Paul Couetil, D Houssin, Olivier Soubrane, Journal of Thoracic and Cardiovascular Surgery TransplantationHepatologyAdvanced Lung DiseaseMedicineTransplantation Medicine	1995	103
Very Late Heart Transplant Rejection Is Associated with Microvascular Injury, Complement Deposition and Progression to Cardiac Allograft Vasculopathy Alexandre Loupy, Aurélie Cazes, R. Guillemain, American Journal of Transplantation	2011	94
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients Marion Berge, R. Guillemain, V. Boussaud, Transplant Infectious Disease	2009	62
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients Maud Berge, R. Guillemain, David‐Alexandre Trégouët, European Journal of Clinical Pharmacology Voriconazole ExposureRespiratory ToxicologyPharmacologyPulmonary PharmacologyPulmonary Fibrosis	2010	60
Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation Marion Tible, Alexandre Loupy, Déwi Vernerey, The Journal of Heart and Lung Transplantation Transplant RejectionTransplantationAutoimmune DiseaseKidney TransplantImmunology	2013	59
Renal Histopathological Lesions After Lung Transplantation in Patients with Cystic Fibrosis Carmen Lefaucheur, Dominique Nochy, C. Amrein, American Journal of Transplantation MedicineKidney TransplantationSurgical PathologyHistopathologyPathology	2008	50
Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients Dominique Farge, J Julien, C. Amrein, Journal of the American College of Cardiology HypertensionUrologyHeart FailureTransplantationCardiovascular Disease	1990	40
Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients Eliane M. Billaud, R. Guillemain, Maud Berge, Medical Mycology	2010	39

Page 1